Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment.

Ison CA.

Curr Opin Infect Dis. 2012 Feb;25(1):73-8. doi: 10.1097/QCO.0b013e32834e9a6a. Review.

PMID:
22143116
2.

The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting.

Whiley DM, Goire N, Lahra MM, Donovan B, Limnios AE, Nissen MD, Sloots TP.

J Antimicrob Chemother. 2012 Sep;67(9):2059-61. doi: 10.1093/jac/dks188. Review.

PMID:
22604449
3.

Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins.

Tapsall JW.

Curr Opin Infect Dis. 2009 Feb;22(1):87-91. doi: 10.1097/QCO.0b013e328320a836. Review.

PMID:
19532086
4.

Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):873-7.

5.

Treatment of uncomplicated infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae.

Klepser ME, Quintiliani R, Nightingale CH.

Conn Med. 1994 Aug;58(8):489-94. Review. No abstract available.

PMID:
7924316
6.

Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.

Matsumoto T.

Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S35-9. doi: 10.1016/j.ijantimicag.2007.08.029.

PMID:
18164598
7.

Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group.

Handsfield HH, Dalu ZA, Martin DH, Douglas JM Jr, McCarty JM, Schlossberg D.

Sex Transm Dis. 1994 Mar-Apr;21(2):107-11.

PMID:
9071422
8.

Global resistance of Neisseria gonorrhoeae: when theory becomes reality.

Lewis DA.

Curr Opin Infect Dis. 2014 Feb;27(1):62-7. doi: 10.1097/QCO.0000000000000025. Review.

PMID:
24275696
9.
10.

Azithromycin in the treatment of infection with Neisseria gonorrhoeae.

Bignell C, Garley J.

Sex Transm Infect. 2010 Nov;86(6):422-6. doi: 10.1136/sti.2010.044586. Review.

PMID:
20940153
11.
12.

Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.

Ison CA, Hussey J, Sankar KN, Evans J, Alexander S.

Euro Surveill. 2011 Apr 7;16(14). pii: 19833.

13.

Emergence and spread of drug resistant Neisseria gonorrhoeae.

Deguchi T, Nakane K, Yasuda M, Maeda S.

J Urol. 2010 Sep;184(3):851-8; quiz 1235. doi: 10.1016/j.juro.2010.04.078. Review.

PMID:
20643433
14.

[Choice of antimicrobial drug for infections caused by Chlamydia trachomatis and Chlamydophila pneumoniae].

Zele-Starcević L, Plecko V, Budimir A, Kalenić S.

Acta Med Croatica. 2004;58(4):329-33. Review. Croatian.

PMID:
15700690
15.

Current and future treatment options for gonorrhoea.

Ison CA, Deal C, Unemo M.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv52-6. doi: 10.1136/sextrans-2012-050913. Review.

PMID:
24106339
16.

Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2011 May 13;60(18):579-81.

17.

Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998.

Dillon JA, Rubabaza JP, Benzaken AS, Sardinha JC, Li H, Bandeira MG, dos Santos Fernando Filho E.

Sex Transm Dis. 2001 Sep;28(9):521-6.

PMID:
11518869
18.

Issues in the management of sexually transmitted diseases in Papua New Guinea.

Passey M.

P N G Med J. 1996 Sep;39(3):252-60. Review.

PMID:
9795576
19.

The role of fluoroquinolones in sexually transmitted diseases.

Tartaglione TA, Hooton TM.

Pharmacotherapy. 1993 May-Jun;13(3):189-201. Review.

PMID:
8321733
20.

Correlation between In vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: a prospective study.

Khaki P, Bhalla P, Sharma A, Kumar V.

Indian J Med Microbiol. 2007 Oct;25(4):354-7.

Supplemental Content

Support Center